Basic Information
Basic information for LINC02223-219-29aa
Peptide Name LINC02223-219-29aa
Genome Position chr5:17926895-17926959,17929358-17929379[+]
Species Human
Peptide Sequence MSCVWFTALTYQLAVNGSATDCNSGSNLK
Peptide Length 29
Unique No (LINC02223-203-29aa,LINC02223-205-29aa,LINC02223-206-29aa,LINC02223-207-29aa,LINC02223-208-29aa,LINC02223-212-29aa,LINC02223-213-29aa,LINC02223-214-29aa,LINC02223-215-29aa,LINC02223-216-29aa)
Grand Average of Hydropathicity 0.1793
Relative Molecular Mass 3586.99
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000249937;LINC02223
Transcript ID/Name ENST00000670782;LINC02223-219
Transcript Length 1596
Coding Ability 0.4392
DNA Sequence Corresponding to Peptide ATGTCATGTGTCTGGTTTACAGCACTCACGTATCAGTTGGCAGTTAACGGAAGTGCTACTGATTGTAACAGTGGAAGCAATTTGAAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :